Ireland - English - HPRA (Health Products Regulatory Authority)

bracco imaging spa - gadobenate dimeglumine - solution for injection - 0.5 mole(s)/litre - paramagnetic contrast media; gadobenic acid

Ireland - English - HPRA (Health Products Regulatory Authority)

bracco imaging spa - gadobenate dimeglumine - solution for injection in pre-filled syringe - 529 milligram(s)/millilitre - paramagnetic contrast media; gadobenic acid

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - gadolinium oxide; dota acid; meglumine; gadoteric acid - solution for injection - 279.32 milligram(s)/millilitre - paramagnetic contrast media; gadoteric acid

Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - gadolinium oxide; dota acid; meglumine - solution for injection - 279.32 milligram(s)/millilitre - paramagnetic contrast media; gadoteric acid

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - gadobenate dimeglumine; gadobenate dimeglumine - injection - 529 mg/ml - gadobenate dimeglumine 529 mg/ml; gadobenate dimeglumine 529 mg/ml

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - gadobenate dimeglumine - injection - 529 mg/ml - gadobenate dimeglumine 529 mg/ml

Singapore - English - HSA (Health Sciences Authority)

dch auriga singapore - gadobenate dimeglumine - injection - 529 mg/ml - gadobenate dimeglumine 529 mg/ml

Israel - English - Ministry of Health

dexcel ltd, israel - gadobenic acid as dimeglumine salt - solution for injection - gadobenic acid as dimeglumine salt 334 mg/ml - gadobenic acid - gadobenic acid - multihance is a paramagnetic contrast agent for use in diagnostic magnetic resonance imaging (mri) indicated for: • mri of the liver for the detection of focal liver lesions in patients with known or suspected primary liver cancer (eg. hepatocellular carcinoma) or metastatic disease.• mri of the brain and spine where it improves the detection of lesions and provides diagnostic information additional to that obtained with unenhanced mri.• contrast-enhanced mr- angiography where it improves the diagnostic accuracy for detecting clinically significant steno-occlusive vascular disease in patients with suspected or known vascular disease of the abdominal or peripheral arteries.• mri of the breast, for the detection of malignant lesions in patients where breast cancer is known or suspected on the basis of previous mammography or ultrasound results

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - gadopentetic acid, dimeglumine salt - injection - 469 mg/ml - gadopentetic acid, dimeglumine salt 469 mg/ml

Malta - English - Medicines Authority

bayer public limited company 400 south oak way, reading berkshire rg2 6ad, united kingdom - gadopentate dimeglumine - solution for injection - gadopentate dimeglumine - contrast media